Complications of catheter cerebral arteriography: analysis of 5,000 procedures. II. Relation of complication rates to clinical and arteriographic diagnoses

Clinical (prearteriographic) and arteriographic diagnoses were grouped into six categories each for analysis of central nervous system and systemic complications of 5,000 catheter cerebral arteriograms. Within each category, there was no significant difference in complication rate between clinical and arteriographic diagnoses. The highest complication rates (1.2%-1.9%) were in patients with cerebrovascular occlusive disease, posttraumatic or postoperative conditions, and subarachnoid hemorrhage. Significantly lower complication rates (0.2%-0.5%) were found in patients with tumor, seizure or headache, and patients with normal arteriographic findings.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. J. Connors III, D. Sacks, A. J. Furlan, W. R. Selman, E. J. Russell, P. E. Stieg, M. N. Hadley, and for the NeuroVascular Coalition Writing Group Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: A Joint Statement from the American Academy of Neurology, the American Association of Neurological Surgeons, the American Society of Interventional and Therapeutic Neuroradiology, the American Society of Neuroradiology, the Congress of Neurological Surgeons, the AANS/CNS Cerebrovascular Section, and the Society of Interventional Radiology Neurology, January 25, 2005; 64(2): 190 - 198. [Full Text] [PDF]

				D. C.C. Johnston, MD;, K. M. Chapman, MD;, and L. B. Goldstein, MD Low rate of complications of cerebral angiography in routine clinical practice Neurology, December 11, 2001; 57(11): 2012 - 2014. [Abstract] [Full Text] [PDF]

				R. Jahan, G. R. Duckwiler, C. S. Kidwell, J. W. Sayre, Y. P. Gobin, J. PabloVillablanca, J. Saver, S. Starkman, N. Martin, and F. Vinuela Intraarterial Thrombolysis for Treatment ofAcute Stroke: Experience in 26 Patients withLong-Term Follow-up AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1291 - 1299. [Abstract] [Full Text]

				G. Rordorf, W. J. Koroshetz, W. A. Copen, G. Gonzalez, K. Yamada, P. W. Schaefer, L. H. Schwamm, C. S. Ogilvy, and A. G. Sorensen Diffusion- and Perfusion-Weighted Imaging in Vasospasm After Subarachnoid Hemorrhage Stroke, March 1, 1999; 30(3): 599 - 605. [Abstract] [Full Text] [PDF]

				G. J DEL ZOPPO, R. VON KUMMER, and G. F HAMANN Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 1 - 9. [Full Text]

				G. J. del Zoppo, R. T. Higashida, A. J. Furlan, M. S. Pessin, H. A. Rowley, and M. Gent PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery Stroke Stroke, January 1, 1998; 29(1): 4 - 11. [Abstract] [Full Text] [PDF]